UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 340

Sortiert nach

Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling

Diabetologia, 2009-11, Vol.52 (11), p.2270-2276

Knop, F. K

2009

Volltextzugriff (PDF)

Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

Diabetologia, 2013-05, Vol.56 (5), p.965-972

2013

Volltextzugriff (PDF)

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

Diabetes, obesity & metabolism, 2012-06, Vol.14 (6), p.500-510

2012

Volltextzugriff (PDF)

N‐terminally and C‐terminally truncated forms of glucose‐dependent insulinotropic polypeptide are high‐affinity competitive antagonists of the human GIP receptor

British journal of pharmacology, 2016-03, Vol.173 (5), p.826-838

2016

Volltextzugriff (PDF)

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

Diabetologia, 2009-02, Vol.52 (2), p.199-207

2009

Volltextzugriff (PDF)

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

British journal of pharmacology, 2016-01, Vol.173 (1), p.27-38

2016

Volltextzugriff (PDF)

Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects

Diabetic medicine, 2013-10, Vol.30 (10), p.1214-1218

2013

Volltextzugriff (PDF)

Regulation of glucagon secretion by incretins

Diabetes, obesity & metabolism, 2011-10, Vol.13 (s1), p.89-94

2011

Volltextzugriff (PDF)

Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies

Diabetes, obesity & metabolism, 2014-11, Vol.16 (11), p.1155-1164

2014

Volltextzugriff (PDF)

Use of antibiotics in childhood and risk of Type 1 diabetes: a population‐based case–control study

Diabetic medicine, 2017-02, Vol.34 (2), p.272-277

2017

Volltextzugriff (PDF)

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

Diabetologia, 2007-04, Vol.50 (4), p.797-805

2007

Volltextzugriff (PDF)

The Pathophysiology of Diabetes Involves a Defective Amplification of the Late-Phase Insulin Response to Glucose by Glucose-Dependent Insulinotropic Polypeptide—Regardless of Etiology and Phenotype

The journal of clinical endocrinology and metabolism, 2003-10, Vol.88 (10), p.4897-4903

2003

Volltextzugriff (PDF)

Reduced Glucose Tolerance and Insulin Resistance Induced by Steroid Treatment, Relative Physical Inactivity, and High-Calorie Diet Impairs the Incretin Effect in Healthy Subjects

The journal of clinical endocrinology and metabolism, 2010-07, Vol.95 (7), p.3309-3317

2010

Volltextzugriff (PDF)

Ghrelin secretion in humans – a role for the vagus nerve?

Neurogastroenterology and motility, 2018-06, Vol.30 (6), p.e13295-n/a

2018

Volltextzugriff (PDF)

Decreased plasma chemerin levels in women with gestational diabetes mellitus

Diabetic medicine, 2014-08, Vol.31 (8), p.936-940

2014

Volltextzugriff (PDF)

Management of people with Type 2 diabetes shared between a specialized outpatient clinic and primary health care is noninferior to management in a specialized outpatient clinic: a randomized, noninferiority trial

Diabetic medicine, 2019-07, Vol.36 (7), p.854-861

2019

Volltextzugriff (PDF)

The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects

European journal of endocrinology, 2014-09, Vol.171 (3), p.353

2014

Volltextzugriff (PDF)

Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus

Diabetes, obesity & metabolism, 2013-08, Vol.15 (8), p.713-720

2013

Volltextzugriff (PDF)

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes

Diabetologia, 2008-04, Vol.51 (4), p.632-640

2008

Volltextzugriff (PDF)

Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele

Diabetes, obesity & metabolism, 2013-01, Vol.15 (1), p.91-95

2013

Volltextzugriff (PDF)

Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature

Diabetes, obesity & metabolism, 2016-05, Vol.18 (5), p.444-453

2016

Volltextzugriff (PDF)

Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis

Regulatory peptides, 2010-09, Vol.164 (2), p.144-150

2010

Volltextzugriff (PDF)

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis

Diabetes, obesity & metabolism, 2016-03, Vol.18 (3), p.300-305

2016

Volltextzugriff (PDF)

Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia

Journal of internal medicine, 2016-05, Vol.279 (5), p.485-493

2016

Volltextzugriff (PDF)

Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists

International journal of clinical practice (Esher), 2009-08, Vol.63 (8), p.1154-1160

2009

Volltextzugriff (PDF)

1 – 25 von 340

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(283)
Mit Volltextzugriff
(301)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling

Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

N‐terminally and C‐terminally truncated forms of glucose‐dependent insulinotropic polypeptide are high‐affinity competitive antagonists of the human GIP receptor

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects

Regulation of glucagon secretion by incretins

Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies

Use of antibiotics in childhood and risk of Type 1 diabetes: a population‐based case–control study

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

The Pathophysiology of Diabetes Involves a Defective Amplification of the Late-Phase Insulin Response to Glucose by Glucose-Dependent Insulinotropic Polypeptide—Regardless of Etiology and Phenotype

Reduced Glucose Tolerance and Insulin Resistance Induced by Steroid Treatment, Relative Physical Inactivity, and High-Calorie Diet Impairs the Incretin Effect in Healthy Subjects

Ghrelin secretion in humans – a role for the vagus nerve?

Decreased plasma chemerin levels in women with gestational diabetes mellitus

Management of people with Type 2 diabetes shared between a specialized outpatient clinic and primary health care is noninferior to management in a specialized outpatient clinic: a randomized, noninferiority trial

The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects

Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes

Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele

Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature

Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis

Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia

Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists

Aktive Filter

Suchergebnisse filtern